You are here: Industry Insights > ASCO

News List

COVID-19: AstraZeneca to distribute masks as ASCO goes virtual pharmatimes
March 26, 2020
As of this morning - Wednesday 25th March - the current recorded case count for COVID-19 (coronavirus) in the UK has hit 8,077, with 422 deaths and 135 recoveries.
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care b3cnewswire
June 27, 2019
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines.
Janssen presents positive Darzalex results at ASCO pharmatimes
June 05, 2019
Janssen Oncology has announced key data on Darzalex (daratumumab) for multiple myeloma at this year’s American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
ASCO: Combo Regimen Effective in CLL With Coexisting Conditions drugs
June 05, 2019
Combo Regimen Effective in CLL With Coexisting Conditions.
ASCO: Survival Up With Ribociclib in Advanced Breast Cancer drugs
June 05, 2019
Survival Up With Ribociclib in Advanced Breast Cancer.
ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever' fiercepharma
June 05, 2019
With ASCO nearing its official close, it's time to round up our favorite quotes from the weekend—a process that's become somewhat of a tradition for us over the last couple of years. Read on to see the most colorful things pharma executives had to say abo
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer drugs
June 04, 2019
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer.
Janssen presents positive Darzalex results at ASCO pharmatimes
June 03, 2019
Janssen Oncology has announced key data on Darzalex (daratumumab) for multiple myeloma at this year’s American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
Cristal Therapeutics to Present Data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on Lead Clinical Candidate CPC634 in Patients With Solid Tumors b3cnewswire
May 20, 2019
Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings.
Low-Fat Diet Could Be a Weapon Against Breast Cancer drugs
May 16, 2019
Low-Fat Diet Could Be a Weapon Against Breast Cancer.

Previous page 1 2 3 4 Next page